| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | 0.027 | 0.6 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.025 | 0.6 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.027 | 0.6 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | -0.038 | 0.6 |